openPR Logo
Press release

Vocal Biomarkers Market - Global Industry Analysis 2024

03-27-2017 07:22 PM CET | Health & Medicine

Press release from: CMI - Healthcare Reports

Vocal Biomarkers – Listening in to Your Body

Sound vibrations are used as part of therapeutic healing for various mental health conditions such as depression and anxiety. Recent research studies, however, have greatly broadened its application into diagnosis of diseases. Biomarkers in the voice of a person have been linked to disorders such as depression, coronary artery disease, and anxiety. On successful completion of clinical trials, HIPAA compliant vocal biomarker system would serve as much more effective alternative to current diagnostic techniques such as MRI, X-Ray, and CT scan. Research is also underway for identifying vocal biomarkers in diagnosis of Parkinson’s disease, traumatic brain injury, cognitive impairment, and respiratory disorders, which would open up a highly lucrative avenue for growth for players in this industry. Companies dealing with voice technology are sampling data to provide accurate results. For instance, Beyond Verbal, Inc. has been researching on vocal biomarkers since 1996, and has collected over 2.5 million voice samples in over 40 different languages.

Get PDF Research Brochure for more Professional and Technical Insights:https://www.coherentmarketinsights.com/insight/request-sample/101

While currently in its very nascent stage with an estimated value of US$ 6.4 million in 2017, the global vocal biomarkers market is expected to expand at a CAGR of 65.7% during the forecast period (2017 – 2028).

Growing Psychological and Cardiovascular Disease Prevalence: A Highly Conducive Growth Environment

Around 350 million people across the globe suffered from depression (WHO, 2016) and approximately 10 million people suffered from Parkinson’s disease globally (Parkinson’s disease Foundation, 2016). Over 235 million people suffered from asthma globally (2016), according to the European Respiratory Society. Diagnosis of these diseases is expensive and thus, is out of reach for most people in emerging economies. This results in high mortality rates in these regions. Vocal biomarker technology systems would act as an ideal cost-effective primary diagnostic tool that could help discern if the patient needs to further opt for expensive X-Ray/MRI/CT/EEG/ECG scans. Thus, millions of suffering from these chronic ailments explicates large potential for vocal biomarkers technology in the commercial space in the long run. Moreover, alterative conventionally used diagnostic systems need to adhere to stringent regulations pertaining to radiation. On the other hand, voice-based systems are based on technology that does not subject the user to any form of radiation and thus, is expected to gain significant traction in the near future.

Rising Demand for Minimally Invasive Techniques to Support the Progress of Vocal Biomarkers Market

Though MRI, CT, X-Ray and ECG, are minimally invasive technologies, they are out of reach for remotely located population. Also, patients prefer minimally invasive procedures as these allow for speedy recovery post procedure. Moreover, high costs of these tests results in substantial healthcare burden for governments and insurance companies alike. Vocal biomarkers is a non-invasive technology and provides great simplicity to an individual. This is therefore analyzed to provide a competitive edge over existing diagnostic technologies that lack the capability to carry preventive diagnosis. Furthermore, this extremely user-friendly system falls perfectly in line with increasing self-diagnosis and self-medication trend, which would significantly fuel demand for vocal biomarkers.

Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/market-insight/vocal-bio-markers-market-101

Strategic Collaborations to Decrease the Turnaround Time for Commercialization of Products

Mr. Charles Marmar (Chairman, Department of Psychiatry, New York University's Langone Medical Center), is conducting a five year study to identify vocal biomarkers for diagnosis of traumatic brain injury (TBI), post-traumatic stress disorder (PTSB), and depression. Initial studies have identified 30 vocal characteristics that seem to be associated with TBI and PTSB. Mr. Marmar has collaborated with SRI International (a non-profit research institute based in California), to identify vocal biomarkers. Beyond Verbal, Inc. is working with Mayo Clinic, Haddassah Medical Center in Jerusalem, Scripps, and Tel Aviv University to expand its vocal biomarker’s research into healthcare sector.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vocal Biomarkers Market - Global Industry Analysis 2024 here

News-ID: 482837 • Views: 173

More Releases from CMI - Healthcare Reports

Biodetection Market - Opportunity Analysis, 2016-2024
Biodetection is witnessing increased acceptance owing to growing bio-terrorism, which in turn results in rising number of illnesses and related deaths. Bioterrorism attacks are carried out using biological agents or biological weapons such as potential pathogens and viruses. Biodetection systems indicate the existence or entry of these pathogens. Bioterrorism attacks are a major concern for governments, as these attacks negatively impact a large population at the same time. For instance,
Augmented Reality in Healthcare Market - Global Industry Insights, Trends and Op …
Technological Advancements to Drive Adoption of Augmented Reality Solutions in North America North America is expected to dominate the global augmented reality in healthcare market size, owing to rising awareness among people and growing demand for augmented reality among people in this region. Moreover, technological advancements in augmented reality is also accentuating market growth in North American. Europe is the next most-dominant market for augmented reality in healthcare market. On an
Augmented Reality in Healthcare Market - Global Industry Insights, Trends, Outlo …
Augmented reality is gaining prominence among medical personnel for various applications ranging from surgical preparation assessment to minimally-invasive surgery and rehabilitation. Various healthcare IT-enabled companies are venturing into the augmented reality in healthcare market to capitalize on the high growth opportunities on offer. The million dollar market is witnessing technology disruption and is expected to grow at a robust double digit CAGR during 2016–2024. Augmented reality is finding wide application
Orthopedic Trauma Devices Market - Global Industry Analysis 2024
Orthopedic Trauma Devices Market Overview Orthopedic trauma is a condition that includes injuries mainly affecting the human skeleton and deteriorating the condition of the subject. It includes the conditions ranging from simple fracture to severe life threatening injuries that are caused due to accidents. Orthopedic trauma includes multiple broken bones across different parts of the body that involve extensive reconstructive surgery. Severe orthopedic traumas can only be treated by fracture specialists

All 5 Releases


More Releases for Vocal

Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
Global Vocal Biomarkers Market to Grow Globally
A person’s voice can serve as an extremely useful tool in identifying the temperament and presence or risk of any disorders such as depression, Parkinson’s disease, and coronary artery disease. Factoring this, scientists from research institutes and companies (dealing with voice and speech technology) are partnering to identify vocal biomarkers that can aid in accurate diagnosis of diseases. Vocal biomarkers technology could be a disruptive innovation in the field of
VOCAL BIOMARKERS MARKET TO REACH US$ 1.6 BILLION BY 2028
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Get Free PDF Research Brochure for more
Vocal Biomarkers Market - Global Industry Analysis 2024
A person’s voice can serve as an extremely useful tool in identifying the temperament and presence or risk of any disorders such as depression, Parkinson’s disease, and coronary artery disease. Factoring this, scientists from research institutes and companies (dealing with voice and speech technology) are partnering to identify vocal biomarkers that can aid in accurate diagnosis of diseases. Vocal biomarkers technology could be a disruptive innovation in the field of
Vocal Biomarkers Market – Global industry insights 2024
Biomarkers form an important tool in the development of targeted drug therapies. Biological markers or Biomarkers are the indicators of normal biological processes, pharmacological responses to a drug and pathogenic processes. They are used to perform clinical assessment for blood pressure, cholesterol level and monitor or predict health state in a person to plan for a therapeutic intervention. They can be in many different forms such as proteins or peptides,
Vocal joins the London First Resilience Network
Vocal Ltd, the CIR Business Continuity Award winning provider of business continuity and emergency communication solutions has joined the London First Resilience Network. The London First Resilience Network’s activities are targeted towards senior security and business continuity personnel in businesses across the capital and shares good practice on policing and business resilience. Ben Howard, Marketing Manager at Vocal said “As the sole providers of priority alerts from the City of London